SPONSOR
University of Maryland, Baltimore
Total Trials
13
Recruiting
13
Phases
Phase 2, Phase 1, Phase 2, Phase 1
Conditions studied: Sickle Cell DiseaseVaso-occlusive Pain Episode in Sickle Cell DiseaseAcute PainHeart Failure，CongestiveLeg EdemaVenous InsufficiencyVenous UlcersHead and Neck CancerHead and Neck Squamous Cell CarcinomaOropharynx Cancer
University of Maryland, Baltimore is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease, Acute Pain, Heart Failure，Congestive.
The trial portfolio spans Phase 2, Phase 1, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Maryland, Baltimore
How many clinical trials has University of Maryland, Baltimore sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by University of Maryland, Baltimore, of which 13 are actively recruiting participants. These trials cover conditions including Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease, Acute Pain. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Maryland, Baltimore research focus on?
University of Maryland, Baltimore clinical trials span Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease, Acute Pain, Heart Failure，Congestive, Leg Edema, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Maryland, Baltimore clinical trial?
To participate in a University of Maryland, Baltimore trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Maryland, Baltimore trials with current recruitment status updated daily.
Clinical Trials by University of Maryland, Baltimore
NCT06184126
Recruiting
Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
Sickle Cell Disease
NCT06350695
Recruiting
The ROle of Compression StocKings in Heart Failure Patients
Heart Failure，Congestive
NCT06088381 Phase 2
Recruiting
Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
Head and Neck Cancer
NCT05511909 Phase 2
Recruiting
Evaluating Buspirone to Treat Opioid Withdrawal
Opioid Use Disorder
NCT02359812
Recruiting
Robot Aided Rehabilitation - Multi-joint Evaluations
Stroke
NCT07075510 Phase 1, Phase 2
Recruiting
Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders
Plasma Cell Disorder
NCT06691269
Recruiting
Photobiomodulation and Tooth Analgesia
Dental Anaesthesia
NCT06472453
Recruiting
Vallomix Socket Preservation Study
Alveolar Ridge Augmentation
NCT04843852 Phase 1
Recruiting
TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
Hepatitis B
NCT06214923
Recruiting
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
Pain
NCT04699773
Recruiting
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
Glioma
NCT06465290
Recruiting
Promoting Neuroplastic Changes of Patients With TBI
Traumatic Brain Injury
NCT04234386
Recruiting
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer
Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology